Skip to main content

Table 3 Patient Participant-Level Measures

From: The PRogram In Support of Moms (PRISM): study protocol for a cluster randomized controlled trial of two active interventions addressing perinatal depression in obstetric settings

Outcome/ Endpoint Measure Administration Time Points*     
    0–24 wks GA 32–40 wks GA 1–3 mos PP 5–7 mos PP 11–13 mos PP
Demographics ➢ Structured interview Research Coordinator (RC) administered   
Depression Severity ➢ EPDS RC administered
Comorbid Anxiety Disorders ➢ GAD-7
➢ PCL-C
RC administered
Knowledge, Attitudes, And Treatment Participation ➢ Structured interview assessing mental health treatment initiation and sustainment and barriers and facilitators to treatment participation Structured interview with RC
Help-Seeking ➢ BACE
➢ PARC-D
RC administered
Infant Bonding ➢ S-PBQ RC administered   
Immature Defenses ➢ DSQ-28 (14 Questions) RC administered    
Obstetric Outcomes ➢ Structured interview assessing obstetric course, birth outcomes (e.g. birth weight, preterm delivery) and infant outcomes Structured interview with RC   
  1. Table 3 represents the time points and frequency at which different patient participant measures are administered according to the PRogram In Support of Moms (PRISM) protocol for the Randomized Controlled Trial (RCT) phase of this study. Measures listed above do not include pre-screen and screening measures done before first time point, including baseline characteristics, MDQ (mood disorder questionnaire), and 4Ps (pregnancy, past, partner, parents) substance abuse screen. Patient participants that are recruited from the holding pool at later gestational ages or postpartum may not complete all measure time points. *Time Points refer to participant’s gestational age (GA) period or postpartum (PP) period in weeks (wks) or months (mos). Demographic questions asked at the time of the initial study phone call with recruitment windows corresponding with the first half of pregnancy, second half of pregnancy, and early postpartum.